(Q37565016)

21 August 2017

1 reference

title

Fibrolamellar hepatocellular carcinoma. (English)

1 reference

fibrolamellar hepatocellular carcinoma

21 August 2017

main subject

0 references

author name string

Shu Liu

1

1 reference

21 August 2017

Kwok Wah Chan

2

1 reference

21 August 2017

Bingyuan Wang

3

1 reference

21 August 2017

Liang Qiao

4

1 reference

21 August 2017

language of work or name

English

0 references

publication date

28 July 2009

1 reference

The American Journal of Gastroenterology

21 August 2017

published in

1 reference

21 August 2017

volume

104

1 reference

21 August 2017

issue

10

1 reference

21 August 2017

page(s)

2617-24; quiz 2625

1 reference

Review of the clinicopathologic features of fibrolamellar carcinoma

21 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2009.440

Malignant liver tumors in South African children: a national audit

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2009.440

Fibrolamellar hepatocellular carcinoma in mexican patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2009.440

Fibrolamellar hepatocellular carcinoma in children and adolescents

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2009.440

Fibrolamellar carcinoma of the liver: an immunohistochemical study of nineteen cases and a review of the literature

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2009.440

Characteristics of fibrolamellar hepatocellular carcinoma. A study of nine cases and a review of the literature

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2009.440

Outcome of patients with fibrolamellar hepatocellular carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2009.440

Fibrolamellar carcinoma of the liver in a Japanese hepatitis B virus carrier

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2009.440

HBV-DNA sequences in tumor and nontumor tissue in a patient with the fibrolamellar variant of hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2009.440

Metastatic liver disease and fulminant hepatic failure: presentation of a case and review of the literature

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2009.440

Budd-Chiari syndrome as the primary manifestation of a fibrolamellar hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2009.440

Fibrolamellar carcinoma: an unusual clinico-radiological presentation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2009.440

Fibrolamellar hepatocellular carcinoma coexistent with a hepatocellular carcinoma of common type: report of a case

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2009.440

Combined fibrolamellar carcinoma and cholangiocarcinoma exhibiting biphenotypic antigen expression: a case report

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2009.440

The fibrolamellar variant of hepatocellular carcinoma. Its association with focal nodular hyperplasia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2009.440

Fibrolamellar hepatocellular carcinoma complicating ulcerative colitis with primary sclerosing cholangitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2009.440

Fine needle aspiration cytodiagnosis of liver tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2009.440

Cytologic aspect of fibrolamellar hepatocellular carcinoma in fine-needle aspirates.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2009.440

Fibrolamellar carcinoma of the liver. Review of three cases and the presentation of a characteristic set of tumor markers defining this tumor

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2009.440

FHIT mRNA and protein expression in hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2009.440

Anterior gradient-2 is overexpressed by fibrolamellar carcinomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2009.440

Report of a complex karyotype in recurrent metastatic fibrolamellar hepatocellular carcinoma and a review of hepatocellular carcinoma cytogenetics

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2009.440

Infrequent chromosome allele loss in fibrolamellar carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2009.440

Distinct chromosomal abnormality pattern in primary liver cancer of non-B, non-C patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2009.440

Fibrolamellar carcinoma of the liver: radiologic-pathologic correlation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2009.440

Treatment of fibrolamellar hepatoma with subtotal hepatectomy or transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2009.440

A case of postoperative recurrence of fibrolamellar hepatocellular carcinoma with increased vitamin B12 binding capacity in a young Japanese female

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2009.440

Role of IV iodinated contrast material in 18F-FDG PET/CT of liver metastases.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2009.440

Multiorgan resection in combination with intraoperative, hyperthermic chemotherapy in recurrent fibrolamellar hepatocellular carcinoma. An individual therapeutic concept for a 21-year-old patient

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2009.440

Phase II trial of systemic continuous fluorouracil and subcutaneous recombinant interferon Alfa-2b for treatment of hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2009.440

Clinical and pathologic factors associated with survival in young adult patients with fibrolamellar hepatocarcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2009.440

The Predictive Value of CK19 and CD99 in Pancreatic Endocrine Tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2009.440

21 January 2018

Identifiers

DOI

10.1038/AJG.2009.440

1 reference

21 August 2017

1 reference